Literature DB >> 9505450

Hepatitis C virus in Zimbabwe.

I T Gangaidzo1, V M Moyo, H Khumalo, T Saungweme, Z Gomo, T Rouault, V R Gordeuk.   

Abstract

BACKGROUND: Hepatitis B is a common cause of chronic liver disease in Zimbabwe but other viral infections are also important. The prevalence of viral hepatitis C has not been previously described in healthy rural Zimbabwean adults.
OBJECTIVES: To determine the prevalence of seropositivity to hepatitis C in rural healthy adults in Zimbabwe, and to determine if there is evidence of active liver disease in subjects who are seropositive. STUDY
DESIGN: Cross sectional descriptive study.
SETTING: Rural communities around different parts of Zimbabwe, as part of a larger study into the prevalence and genetic pattern of iron overload.
SUBJECTS: An initial 150 rural Zimbabweans over the age of 12 years. MAIN OUTCOME MEASURES: Presence of the following serological markers: hepatitis B surface antigen; antibodies to hepatitis C, B surface and B core antigens; hepatic enzymes and iron status determined on the basis of serum ferritin and transferrin saturation.
RESULTS: 11 (7.7%) of the subjects were positive for antibodies to hepatitis C and they had significant elevations in hepatic enzymes and serum iron levels suggesting substantial hepatocellular damage. Twenty (14.1%) of the subjects were positive for hepatitis B surface antigen, but they did not have significant elevations in hepatic enzymes or indirect measures of iron status.
CONCLUSION: Seropositivity for hepatitis C is common and is approximately half the prevalence of hepatitis B chronic carrier status. Chronic hepatitis C may be more damaging to the liver than chronic hepatitis B and, therefore, may be an important cause of liver disease in rural Zimbabwe.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9505450

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  3 in total

Review 1.  Hepatitis C treatment: current and future perspectives.

Authors:  Saira Munir; Sana Saleem; Muhammad Idrees; Aaliyah Tariq; Sadia Butt; Bisma Rauff; Abrar Hussain; Sadaf Badar; Mahrukh Naudhani; Zareen Fatima; Muhmmad Ali; Liaqat Ali; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Zunaira Awan
Journal:  Virol J       Date:  2010-11-01       Impact factor: 4.099

2.  Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe.

Authors:  Nyasha Chin'ombe; Evans Chavhunduka; Hilda T Matarira
Journal:  Infect Agent Cancer       Date:  2009-10-08       Impact factor: 2.965

3.  Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges.

Authors:  Blessing Dzingirai; Leolin Katsidzira; Celia Moffat Joel Matyanga; Maarten Jacobus Postma; Marinus van Hulst; Nyashadzaishe Mafirakureva
Journal:  J Viral Hepat       Date:  2021-04-09       Impact factor: 3.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.